Adam S. Feldman, MD, MPH, is a urologist at the Massachusetts General Hospital Department of Urology. He specializes in the treatment of cancer and related research.



Centers & Specialties

Cancer Center

Clinical Interests
  • Prostate cancer
  • Kidney cancer
  • Bladder cancer
  • Testicular, penile and genitourinary cancers
  • Laparoscopic surgery
  • Robotic surgery
  • Brachytherapy (radioactive seeds)
Medical Education
  • MPH, Harvard School of Public Health
  • MD, University of Massachusetts Medical School
  • Residency, Massachusetts General Hospital
Board Certifications
  • Urology
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Dr. Adam Feldman is a faculty member of the Department of Urology and a Urologic Oncologist at Massachusetts General Hospital. Dr. Feldman completed his residency in urology in 2006 and subsequently completed his fellowship in urologic oncology in June 2008. His clinical practice is focused on the surgical management of genitourinary cancer using both open and laparoscopic techniques. Dr. Feldman also is involved in clinical and translational research in cancers of the prostate, bladder, kidney and penis. He recently received a three year Young Investigator Award from the Prostate Cancer Foundation for his work in biomarker discovery and analysis in prostate cancer.

Edit Profile

Research & Publications


View my most recent publications at PubMed

Feldman AS, Banyard J, Wu C-L, et al. Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res. 2009;15(3):1024-31.

Kaufman DS, Shipley WU, Feldman AS. Bladder Cancer. The Lancet. 2009; 374(9685):239-49.

Feldman AS and Dahl DM. , 2006. June, 2-6, 2006. Laparoscopic Radical Prostatectomy. US Oncological Disease 2006. 2006: pp. 56-58.

Feldman AS, McDougal WS, Harisinghani MG. The potential of nanoparticle-enhanced imaging. The Journal of Urologic Oncology, Seminar Section. 2008;26(1):65-73.

Feldman AS, Daha AK, Osbourne AL, et al. Case-matched analysis of radiofrequency ablation vs. open and laparoscopic partial nephrectomy: What is the effect on GFR? Accepted for presentation at the ASCO GU Cancer Symposium, 2010.

Edit Profile

News & Events

  • MGH and CBS care

    MGH Hotline 02.04.11 To promote awareness about the disease and the importance of self-exams, the MGH and CBS Cares are collaborating on a fun, informative public service announcement (PSA).



Mass General Urology Associates
15 Parkman St
Boston MA, 02114-3117
Phone: 617-643-1955

Edit Profile